NCT02225405
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Stage IB Non-Small Cell Lung Carcinoma AJCC v7
Explore clinical trials studying Stage IB Non-Small Cell Lung Carcinoma AJCC v7. Study availability and eligibility vary by location and protocol.
3 public trials
0 recruiting studies
Stage IB Non-Small Cell Lung Carcinoma AJCC v7 trial results
NCT03493789
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +15 more
- Locations
-
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
Active, Not Recruiting
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)
NCT02201992
- Conditions
- ALK Gene Rearrangement, ALK Gene Translocation, ALK Positive, +15 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Southern Cancer Center PC-Daphne Daphne, Alabama, United States
- Southern Cancer Center PC-Mobile Mobile, Alabama, United States
- Southern Cancer Center PC-Providence Mobile, Alabama, United States